Long-term follow-up after liver transplantation for erythropoietic protoporphyria

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 4, 1999, Pages 431-438

  Meerman, Leo ^a   Haagsma, Elizabeth B ^a   Gouw, Annette S H ^a   Slooff, Maarten J H ^a   Jansen, Peter L M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cirrhosis; Erythropoietic protoporphyria; Liver transplantation

Indexed keywords

ACETYLCYSTEINE; PORPHYRIN; URSODEOXYCHOLIC ACID;

ADULT; BLOOD LEVEL; BLOOD TRANSFUSION; BONE MARROW; CASE REPORT; CHOLESTASIS; ERYTHROPOIETIC PROTOPORPHYRIA; FECES ANALYSIS; FEMALE; FOLLOW UP; HEME SYNTHESIS; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW;

EID: 0032923465     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199904000-00012     Document Type: Review

References (37)

1. Whitcombe DM, Carter NP, Albertson DG, Smith SJ, Rhodes DA, Cox TM. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporhyria to chromosome 18q22. Genomics 1991; 11:1152-1154.
2. Lamoril J, Boulechfar S, de Verneuil H, Grandchamp B, Nordmann Y, Deybach J-C. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun 1991; 181:594-599.
3. Bonkowsky HL, Bloomer JR, Mahoney MJ, Ebert PS. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest 1975; 56:1139-1148.
4. Bloomer JR, Bonkowsky HL, Ebert PS, Mahoney MJ. Inheritance in protoporphyria: comparison of heme synthetase activity in skin fibroblasts with clinical features. Lancet 1976; ii:226-228.
5. Poh-Fitzpatrick MB. Protoporphyrin metabolic balance in human protoporphyria. Gastroenterology 1985; 88:1239-1242.
6. Bloomer JR, Hill HD, Kools AM, Straka JG. Heme synthesis in protoporphyria. Curr Probl Dermatol 1991; 20:135-147.
7. Morton KO, Schneider F, Weimer MK, Straka JG, Bloomer JR. Hepatic and bile porphyrins in patients with protoporphyria and liver failure. Gastroenterology 1988; 94:1488-1492.
8. Cripps DJ, Gilbert LA, Goldfarb S. Erythropoietic protoporphyria: juvenile protoporphyrin hepatopathy, cirrhosis and death. J Pediatr 1977; 91:744-748.
9. Avner DL, Lee RG, Berenson MM. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest 1981; 67:385-394.
10. Avner DL, Larsen R, Berenson MM. Inhibition of liver surface membrane, Na, K-adenosine triphosphatase, Mg-adenosine triphosphatase and 5′-nucleotidase activities by protoporphyrin. Observation in vitro and in the perfused rat liver. Gastroenterology 1983; 85:700-706.
11. Bloomer JR, Phillips MJ, Davidson DL, Klatskin G. Hepatic disease in erythropoietic protoporphyria. Am J Med 1975; 58:869-882.
12. Bonkowsky HL, Schned AR. Fatal liver failure in protoporphyria. Gastroenterology 1986; 90:191-201.
13. Wells MM, Golitz LE, Bender BJ. Erythropoietic protoporphyria with hepatic cirrhosis. Arch Dermatol 1980; 116:429-432.
14. Samuel D, Boboc B, Bemau J, Bismuth H, Benhamou JP. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction. Gastroenterology 1988; 95:816-819.
15. Polson RJ, Lim CK, Rolles K, Calne RY, Williams R. The effect of liver transplantation in a 13-year old boy with erythropoietic protoporphyria. Transplantation 1988; 46:386-389.
16. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology 1989; 97:188-194.
17. Wagner S, Doss MO, Eittekind C, Bäcker U, Meessen D, Schmidt FW. Erythrohepatische Protoporphyrie mit rasch progredienter Leberzirrhose. Dtsch Med Wochenschr 1989; 114:1837-1841.
18. Herbert A, Corbin D, Williams A, Thompson D, Bucckels J, Elias E. Erythropoielic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 1991; 100:1753-1757.
19. Mion FBC, Faure J-L, Berger F, McGregor B, Perrot H, Paliard P. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol 1992; 16:203-207.
20. Steinmuller T, Doss MO, Steffen R, Blumhardt G, Bechstein WO, Frank M, et al. Lebertransplantation bei erythrohepatischer Protoporphyrie. Dtsch Med Wochenschr 1992; 117:1097-1102.
21. Schleiffenbaum BE, Minder EI, Mohr P, Decurtins M, Schaffner A. Cytofluorometry as a diagnosis of protoporphyria. Gastroenterology 1992; 102:1044-1048.
22. Key NS, Rank JM, Freese D, Bloomer JR, Hammerschmidt DE. Hemolytic anemia in protoporphyria: possible precipitating role of liver failure and photic stress. Am J Hematol 1992; 39:202-207.
23. Rank JM, Carithers R, Bloomer J. Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology 1993; 18:1404-1409.
24. Potter C, Tolaymat N, Bobo R, Sharp H, Rank J, Bloomer J. Hematin therapy in children with protoporphyric liver disease. J Pediatr Gastroenterol Nutr 1996; 23:402-407.
25. Lock G, Holstege A, Mueller AR, Christe W, Doss MO, Schölmerich J, et al. Liver failure in erythropoietic protoporphyria associated with choledocholithiasis and severe post-transplantation polyneuropathy. Liver 1996; 16:211-217.
26. De Torres I, Demetris AJ, Randhawa PS. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 1995; 61:1412-1413.
27. Starzl TE. Experience in Hepatic Transplantation. Philadelphia: Saunders; 1969.
28. Starzl TE, Iwatsuki S, Shaw BE. Factors in the development of liver transplantation. Transplant Proc 1985; 17:107-119.
29. Meerman L, Verwer R, Slooff MJH, van Hattum J, Beukeveld GJ, Kleibeuker JH, et al. Perioperative measures during liver transplantation for orythropoietic protoporphyria. Transplantation 1994; 57:155-158.
30. Kappas A, Sassa S, Galbrait RA, Nordmann Y. The prophyrias. In: The Metabolic Basis of Inherited Disease, 6th edn. Scriver CR, Beaudet AL, Sly WS, Valle D (editors). New York: McGraw-Hill; 1989. pp. 1305-1365.
31. Beukeveld GJJ, Nagel GT, de Ruyter-Buitenhuis AW, Kwarts EW, Wolthers BG. Determination of porphyrins in blood, urine and faeces by means of HPLC and its application in establishing porphyria. Biochim Clin 1987; 11:203-213.
32. van Hilligersberg R, van den Berg JWO, Kort WJ, Terpstra OT, Wilson JHP. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 1992; 103:647-651.
33. Mooyaart BR, de Jong GMTh, van der Veen S, Driessen LHHM, Beukeveld GJJ, Grond J, et al. Hepatic disease in erythropoietic protoporphyria. Dermatologica 1986; 173:120-130.
34. Rademakers LHPM, Cleton MI, Kooyman C, Baart de la Faille H, van Hattum J. Early involvement of hepatic parenchymal cells in erythropoietic protoporphyria. An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology 1990; 11:449-457.
35. Doss MO, Frank M. Hepatobiliary implications in protoporphyria: a 20 year study. Clin Biochem 1989; 22:223-229.
36. Berenson MM, Gunther C, Samowitz WS, Bjorkman DJ. Formation of biliary thrombi in protoporphytin-induced cholestasis in perfused rat liver. Hepatology 1990; 11:757-763.
37. Koningsberger JC. The Dark Side of Protoporphyria. Thesis, University of Utrecht, 1992.